// App-Quantinova.ai

: Long Term Follow-up of International Randomised Phase 3 Study of Rituximab Versus a Watch and Wait Approach for Patients with Asymptomatic, Low Tumour Burden Follicular Lymphoma Shows Rituximab Is Highly Effective at Delaying Time to New Treatment without Detrimental Impact Following Next Line of Therapy

Researchers

Presenter

  • Michael Northend

Principal Investigators

  • William Wilson

  • Laura Clifton-Hadley

  • Zaynab Rana

  • Tanya-Louise Martin

  • Moya Young

  • Fiona Miall

  • David Cunningham

  • Jan Walewski

  • Burhan Ferhanoglu

  • Amanda Johnston

  • John F. Seymour

  • David C. Linch

  • Kirit M. Ardeshna

Medical Centers

  • Peter MacCallum Cancer Centre & the Royal Melbourne Hospital, Melbourne, Victoria, Australia

  • University College London, London, United Kingdom

  • Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom

  • Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom

  • Kent and Canterbury Hospital, East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom

  • The Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom

  • Hematology Department, Koç University, School of Medicine, Istanbul, Turkey

  • Westmead Hospital, Westmead, Australia

  • University Hospitals of Leicester NHS Trust, Leicester, United Kingdom

  • Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland

Locations

  • Australia

  • United Kingdom

  • Turkey

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

  • Techniclone TNT

Outcome

  • N/A

Study Design

  • Randomized

  • Efficacy

  • Multiple Arm

  • Multinational

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved